Celiac disease is a chronic autoimmune disorder in which the body’s immune system mistakenly attacks the small intestine. It is triggered by the consumption of gluten, a protein found in wheat, barley and rye. The immune reaction damages the tiny finger-like projections (villi) lining the small intestine. As a result, it reduces the body’s ability to absorb nutrients from food. [Read more…]
Cell Therapy CDMO Cellipont Bioservices Celebrates Major Manufacturing Milestone: Releases 100th GMP Batch
Cell therapy CDMO reaches major manufacturing milestone approximately one year after initiating GMP operations at its Texas facility
THE WOODLANDS, Texas, July 28, 2026 — Cellipont Bioservices, a cell therapy contract development and manufacturing organization, announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas.
The achievement is especially significant given that Cellipont initiated GMP manufacturing operations at the facility in June 2025. Reaching 100 GMP batch releases in approximately one year reflects the strength of the company’s operational infrastructure, the growing demand from its clients, and the dedication of its cross-functional teams. [Read more…]
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
New agreement secures flexible and scalable manufacturing to support the U.S. commercial and global clinical supply of miv-cel
EMERYVILLE, Calif., and WALTHAM, Mass., July 27, 2026 — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, and ElevateBio, a technology-driven advanced therapy contract development and manufacturing organization (CDMO), today announced a manufacturing agreement for both U.S. commercial and global clinical supply of miv-cel (mivocabtagene autoleucel), Kyverna’s autologous CD19-directed CAR T-cell therapy. [Read more…]
STAT6 as a Diagnostic Marker in Solitary Fibrous Tumors and Soft Tissue Neoplasms
Accurate tumor classification guides diagnosis, prognosis, and treatment decisions. This is particularly essential when morphologically similar tumors arise from different tissue lineages. STAT6 (signal transducer and activator of transcription 6) has emerged as a valuable diagnostic marker, as its expression pattern can help distinguish specific mesenchymal neoplasms from their histologic mimics. [Read more…]
Guide To The Stem Cell Donation Process
Stem cell donation can be an overwhelming topic for those considering it. However, the procedure itself is often simple to undergo. Here are the key aspects associated with the the stem cell donation process. [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 64
- Next Page »